 | • レポートコード：GIR201100229 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、アクチビン受容体タイプ1の世界市場を調査対象にし、アクチビン受容体タイプ1の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（LJPC-6417、TP-0184、ジピリダモール、その他）、用途別分析（アルポート症候群、慢性腎疾患、腎線維症、肥満、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Blueprint Medicines Corp、Oncodesign SA、Daiichi Sankyo Company Ltd、La Jolla Pharmaceutical Company、Tolero Pharmaceuticals Inc ・メーカー別販売量、売上、市場シェア ・アクチビン受容体タイプ1の地域別市場分析 ・アクチビン受容体タイプ1の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・アクチビン受容体タイプ1のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・アクチビン受容体タイプ1のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・アクチビン受容体タイプ1の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・アクチビン受容体タイプ1の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・アクチビン受容体タイプ1の種類別市場規模2015-2020：LJPC-6417、TP-0184、ジピリダモール、その他 ・アクチビン受容体タイプ1の用途別市場規模2015-2020：アルポート症候群、慢性腎疾患、腎線維症、肥満、その他 ・アクチビン受容体タイプ1の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Activin Receptor Type 1 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Activin Receptor Type 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Activin Receptor Type 1 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Activin Receptor Type 1 market has been segmented into
LJPC-6417
TP-0184
Dipyridamole
Others
By Application, Activin Receptor Type 1 has been segmented into:
Alport Syndrome
Chronic Kidney Disease
Kidney Fibrosis
Obesity
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Activin Receptor Type 1 market presented in the report. This section sheds light on the sales growth of different regional and country-level Activin Receptor Type 1 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Activin Receptor Type 1 market.
The report offers in-depth assessment of the growth and other aspects of the Activin Receptor Type 1 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Activin Receptor Type 1 Market Share Analysis
Activin Receptor Type 1 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Activin Receptor Type 1 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Activin Receptor Type 1 sales, revenue and market share for each player covered in this report.
The major players covered in Activin Receptor Type 1 are:
Blueprint Medicines Corp
Oncodesign SA
Daiichi Sankyo Company Ltd
La Jolla Pharmaceutical Company
Tolero Pharmaceuticals Inc
Among other players domestic and global, Activin Receptor Type 1 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Activin Receptor Type 1 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Activin Receptor Type 1, with price, sales, revenue and global market share of Activin Receptor Type 1 in 2018 and 2019.
Chapter 3, the Activin Receptor Type 1 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Activin Receptor Type 1 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Activin Receptor Type 1 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Activin Receptor Type 1 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Activin Receptor Type 1 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Activin Receptor Type 1 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 LJPC-6417
1.2.3 TP-0184
1.2.4 Dipyridamole
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Activin Receptor Type 1 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Alport Syndrome
1.3.3 Chronic Kidney Disease
1.3.4 Kidney Fibrosis
1.3.5 Obesity
1.3.6 Others
1.4 Overview of Global Activin Receptor Type 1 Market
1.4.1 Global Activin Receptor Type 1 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Blueprint Medicines Corp
2.1.1 Blueprint Medicines Corp Details
2.1.2 Blueprint Medicines Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Blueprint Medicines Corp SWOT Analysis
2.1.4 Blueprint Medicines Corp Product and Services
2.1.5 Blueprint Medicines Corp Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Oncodesign SA
2.2.1 Oncodesign SA Details
2.2.2 Oncodesign SA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Oncodesign SA SWOT Analysis
2.2.4 Oncodesign SA Product and Services
2.2.5 Oncodesign SA Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Daiichi Sankyo Company Ltd
2.3.1 Daiichi Sankyo Company Ltd Details
2.3.2 Daiichi Sankyo Company Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Daiichi Sankyo Company Ltd SWOT Analysis
2.3.4 Daiichi Sankyo Company Ltd Product and Services
2.3.5 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 La Jolla Pharmaceutical Company
2.4.1 La Jolla Pharmaceutical Company Details
2.4.2 La Jolla Pharmaceutical Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 La Jolla Pharmaceutical Company SWOT Analysis
2.4.4 La Jolla Pharmaceutical Company Product and Services
2.4.5 La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Tolero Pharmaceuticals Inc
2.5.1 Tolero Pharmaceuticals Inc Details
2.5.2 Tolero Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Tolero Pharmaceuticals Inc SWOT Analysis
2.5.4 Tolero Pharmaceuticals Inc Product and Services
2.5.5 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Activin Receptor Type 1 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Activin Receptor Type 1 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Activin Receptor Type 1 Manufacturer Market Share in 2019
3.3.2 Top 6 Activin Receptor Type 1 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Activin Receptor Type 1 Sales, Revenue and Market Share by Regions
4.1.1 Global Activin Receptor Type 1 Sales and Market Share by Regions (2015-2020)
4.1.2 Global Activin Receptor Type 1 Revenue and Market Share by Regions (2015-2020)
4.2 North America Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
4.3 Europe Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
4.5 South America Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Activin Receptor Type 1 Sales, Revenue and Market Share by Country
5.1.1 North America Activin Receptor Type 1 Sales and Market Share by Country (2015-2020)
5.1.2 North America Activin Receptor Type 1 Revenue and Market Share by Country (2015-2020)
5.2 United States Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
5.3 Canada Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
5.4 Mexico Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Activin Receptor Type 1 Sales, Revenue and Market Share by Country
6.1.1 Europe Activin Receptor Type 1 Sales and Market Share by Country (2015-2020)
6.1.2 Europe Activin Receptor Type 1 Revenue and Market Share by Country (2015-2020)
6.2 Germany Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
6.3 UK Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
6.4 France Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
6.5 Russia Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
6.6 Italy Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Activin Receptor Type 1 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Activin Receptor Type 1 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Activin Receptor Type 1 Revenue and Market Share by Regions (2015-2020)
7.2 China Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
7.3 Japan Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
7.4 Korea Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
7.5 India Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
7.7 Australia Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Activin Receptor Type 1 Sales, Revenue and Market Share by Country
8.1.1 South America Activin Receptor Type 1 Sales and Market Share by Country (2015-2020)
8.1.2 South America Activin Receptor Type 1 Revenue and Market Share by Country (2015-2020)
8.2 Brazil Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
8.3 Argentina Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Activin Receptor Type 1 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Activin Receptor Type 1 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Activin Receptor Type 1 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
9.3 Turkey Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
9.4 Egypt Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
9.5 South Africa Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Activin Receptor Type 1 Sales and Market Share by Type (2015-2020)
10.2 Global Activin Receptor Type 1 Revenue and Market Share by Type (2015-2020)
10.3 Global Activin Receptor Type 1 Price by Type (2015-2020)
11 Global Activin Receptor Type 1 Market Segment by Application
11.1 Global Activin Receptor Type 1 Sales Market Share by Application (2015-2020)
11.2 Global Activin Receptor Type 1 Revenue Market Share by Application (2015-2020)
11.3 Global Activin Receptor Type 1 Price by Application (2015-2020)
12 Market Forecast
12.1 Global Activin Receptor Type 1 Sales, Revenue and Growth Rate (2021-2025)
12.2 Activin Receptor Type 1 Market Forecast by Regions (2021-2025)
12.2.1 North America Activin Receptor Type 1 Market Forecast (2021-2025)
12.2.2 Europe Activin Receptor Type 1 Market Forecast (2021-2025)
12.2.3 Asia-Pacific Activin Receptor Type 1 Market Forecast (2021-2025)
12.2.4 South America Activin Receptor Type 1 Market Forecast (2021-2025)
12.2.5 Middle East & Africa Activin Receptor Type 1 Market Forecast (2021-2025)
12.3 Activin Receptor Type 1 Market Forecast by Type (2021-2025)
12.3.1 Global Activin Receptor Type 1 Sales Forecast by Type (2021-2025)
12.3.2 Global Activin Receptor Type 1 Market Share Forecast by Type (2021-2025)
12.4 Activin Receptor Type 1 Market Forecast by Application (2021-2025)
12.4.1 Global Activin Receptor Type 1 Sales Forecast by Application (2021-2025)
12.4.2 Global Activin Receptor Type 1 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Activin Receptor Type 1 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Activin Receptor Type 1 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Activin Receptor Type 1 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Blueprint Medicines Corp Basic Information, Manufacturing Base and Competitors
Table 8. Blueprint Medicines Corp Activin Receptor Type 1 Major Business
Table 9. Blueprint Medicines Corp Activin Receptor Type 1 Total Revenue (USD Million) (2018-2019)
Table 10. Blueprint Medicines Corp SWOT Analysis
Table 11. Blueprint Medicines Corp Activin Receptor Type 1 Product and Services
Table 12. Blueprint Medicines Corp Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Oncodesign SA Basic Information, Manufacturing Base and Competitors
Table 14. Oncodesign SA Activin Receptor Type 1 Major Business
Table 15. Oncodesign SA Activin Receptor Type 1 Total Revenue (USD Million) (2018-2019)
Table 16. Oncodesign SA SWOT Analysis
Table 17. Oncodesign SA Activin Receptor Type 1 Product and Services
Table 18. Oncodesign SA Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Daiichi Sankyo Company Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Daiichi Sankyo Company Ltd Activin Receptor Type 1 Major Business
Table 21. Daiichi Sankyo Company Ltd Activin Receptor Type 1 Total Revenue (USD Million) (2018-2019)
Table 22. Daiichi Sankyo Company Ltd SWOT Analysis
Table 23. Daiichi Sankyo Company Ltd Activin Receptor Type 1 Product and Services
Table 24. Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. La Jolla Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 26. La Jolla Pharmaceutical Company Activin Receptor Type 1 Major Business
Table 27. La Jolla Pharmaceutical Company Activin Receptor Type 1 Total Revenue (USD Million) (2018-2019)
Table 28. La Jolla Pharmaceutical Company SWOT Analysis
Table 29. La Jolla Pharmaceutical Company Activin Receptor Type 1 Product and Services
Table 30. La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Tolero Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 32. Tolero Pharmaceuticals Inc Activin Receptor Type 1 Major Business
Table 33. Tolero Pharmaceuticals Inc Activin Receptor Type 1 Total Revenue (USD Million) (2018-2019)
Table 34. Tolero Pharmaceuticals Inc SWOT Analysis
Table 35. Tolero Pharmaceuticals Inc Activin Receptor Type 1 Product and Services
Table 36. Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Activin Receptor Type 1 Sales by Manufacturer (2018-2019) (K Pcs)
Table 38. Global Activin Receptor Type 1 Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Activin Receptor Type 1 Sales by Regions (2015-2020) (K Pcs)
Table 40. Global Activin Receptor Type 1 Sales Market Share by Regions (2015-2020)
Table 41. Global Activin Receptor Type 1 Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Activin Receptor Type 1 Sales by Countries (2015-2020) (K Pcs)
Table 43. North America Activin Receptor Type 1 Sales Market Share by Countries (2015-2020)
Table 44. North America Activin Receptor Type 1 Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Activin Receptor Type 1 Revenue Market Share by Countries (2015-2020)
Table 46. Europe Activin Receptor Type 1 Sales by Countries (2015-2020) (K Pcs)
Table 47. Europe Activin Receptor Type 1 Sales Market Share by Countries (2015-2020)
Table 48. Europe Activin Receptor Type 1 Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Activin Receptor Type 1 Sales by Regions (2015-2020) (K Pcs)
Table 50. Asia-Pacific Activin Receptor Type 1 Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Activin Receptor Type 1 Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Activin Receptor Type 1 Sales by Countries (2015-2020) (K Pcs)
Table 53. South America Activin Receptor Type 1 Sales Market Share by Countries (2015-2020)
Table 54. South America Activin Receptor Type 1 Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Activin Receptor Type 1 Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Activin Receptor Type 1 Sales by Countries (2015-2020) (K Pcs)
Table 57. Middle East & Africa Activin Receptor Type 1 Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Activin Receptor Type 1 Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Activin Receptor Type 1 Revenue Market Share by Countries (2015-2020)
Table 60. Global Activin Receptor Type 1 Sales by Type (2015-2020) (K Pcs)
Table 61. Global Activin Receptor Type 1 Sales Share by Type (2015-2020)
Table 62. Global Activin Receptor Type 1 Revenue by Type (2015-2020) (USD Million)
Table 63. Global Activin Receptor Type 1 Revenue Share by Type (2015-2020)
Table 64. Global Activin Receptor Type 1 Sales by Application (2015-2020) (K Pcs)
Table 65. Global Activin Receptor Type 1 Sales Share by Application (2015-2020)
Table 66. Global Activin Receptor Type 1 Sales Forecast by Regions (2021-2025) (K Pcs)
Table 67. Global Activin Receptor Type 1 Market Share Forecast by Regions (2021-2025)
Table 68. Global Activin Receptor Type 1 Sales Forecast by Type (2021-2025) (K Pcs)
Table 69. Global Activin Receptor Type 1 Market Share Forecast by Type (2021-2025)
Table 70. Global Activin Receptor Type 1 Sales Forecast by Application (2021-2025)
Table 71. Global Activin Receptor Type 1 Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Activin Receptor Type 1 Picture
Figure 2. Global Sales Market Share of Activin Receptor Type 1 by Type in 2019
Figure 3. LJPC-6417 Picture
Figure 4. TP-0184 Picture
Figure 5. Dipyridamole Picture
Figure 6. Others Picture
Figure 7. Activin Receptor Type 1 Sales Market Share by Application in 2018
Figure 8. Alport Syndrome Picture
Figure 9. Chronic Kidney Disease Picture
Figure 10. Kidney Fibrosis Picture
Figure 11. Obesity Picture
Figure 12. Others Picture
Figure 13. Global Activin Receptor Type 1 Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Activin Receptor Type 1 Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Activin Receptor Type 1 Sales Market Share by Manufacturer in 2019
Figure 34. Global Activin Receptor Type 1 Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Activin Receptor Type 1 Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Activin Receptor Type 1 Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 39. Global Activin Receptor Type 1 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Activin Receptor Type 1 Revenue Market Share by Regions (2015-2020)
Figure 41. Global Activin Receptor Type 1 Revenue Market Share by Regions in 2018
Figure 42. North America Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
Figure 43. Europe Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
Figure 45. South America Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Activin Receptor Type 1 Sales and Growth Rate (2015-2020)
Figure 47. North America Activin Receptor Type 1 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Activin Receptor Type 1 Sales Market Share by Countries (2015-2020)
Figure 49. North America Activin Receptor Type 1 Sales Market Share by Countries in 2018
Figure 50. North America Activin Receptor Type 1 Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Activin Receptor Type 1 Revenue Market Share by Countries in 2018
Figure 52. United States Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Canada Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Mexico Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Europe Activin Receptor Type 1 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Activin Receptor Type 1 Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Activin Receptor Type 1 Revenue Market Share by Countries in 2019
Figure 58. Germany Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. UK Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. France Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Italy Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Asia-Pacific Activin Receptor Type 1 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Activin Receptor Type 1 Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Activin Receptor Type 1 Revenue Market Share by Regions 2019
Figure 66. China Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Korea Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. India Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Southeast Asia Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. South America Activin Receptor Type 1 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Activin Receptor Type 1 Sales Market Share by Countries in 2019
Figure 73. South America Activin Receptor Type 1 Revenue Market Share by Countries in 2019
Figure 74. Brazil Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Argentina Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Middle East and Africa Activin Receptor Type 1 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Activin Receptor Type 1 Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Activin Receptor Type 1 Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Activin Receptor Type 1 Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Egypt Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Turkey Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. South Africa Activin Receptor Type 1 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Global Activin Receptor Type 1 Sales and Growth Rate (2021-2025) (K Pcs)
Figure 85. Global Activin Receptor Type 1 Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Activin Receptor Type 1 Market Forecast (2021-2025) (K Pcs)
Figure 87. Europe Sales Activin Receptor Type 1 Market Forecast (2021-2025) (K Pcs)
Figure 88. Asia-Pacific Sales Activin Receptor Type 1 Market Forecast (2021-2025) (K Pcs)
Figure 89. South America Sales Activin Receptor Type 1 Market Forecast (2021-2025) (K Pcs)
Figure 90. Middle East & Africa Sales Activin Receptor Type 1 Market Forecast (2021-2025) (K Pcs)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
Gタンパク質共役胆汁酸受容体1の世界市場 2020年 Market Overview The global G Protein Coupled Bile Acid Receptor 1 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The G Prot…- ソマトスタチン受容体4型の世界市場 2020年 Market Overview The global Somatostatin Receptor Type 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Somatostatin Rec…
- グルカゴン様ペプチド2受容体の世界市場 2020年 Market Overview The global Glucagon Like Peptide 2 Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glucagon Lik…
- ニューロペプチドY受容体タイプ2の世界市場 2020年 Market Overview The global Neuropeptide Y Receptor Type 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neuropeptide Y…
- メラニン濃縮ホルモン受容体1の世界市場 2020年 Market Overview The global Melanin Concentrating Hormone Receptor 1 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mela…